Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;27(4):1007-1014.
doi: 10.3201/eid2704.203569.

Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020

Review

Reemergence of Human Monkeypox and Declining Population Immunity in the Context of Urbanization, Nigeria, 2017-2020

Phi-Yen Nguyen et al. Emerg Infect Dis. 2021 Apr.

Abstract

A monkeypox outbreak in Nigeria during 2017-2020 provides an illustrative case study for emerging zoonoses. We built a statistical model to simulate declining immunity from monkeypox at 2 levels: At the individual level, we used a constant rate of decline in immunity of 1.29% per year as smallpox vaccination rates fell. At the population level, the cohort of vaccinated residents decreased over time because of deaths and births. By 2016, only 10.1% of the total population in Nigeria was vaccinated against smallpox; the serologic immunity level was 25.7% among vaccinated persons and 2.6% in the overall population. The substantial resurgence of monkeypox in Nigeria in 2017 appears to have been driven by a combination of population growth, accumulation of unvaccinated cohorts, and decline in smallpox vaccine immunity. The expanding unvaccinated population means that entire households, not just children, are now more susceptible to monkeypox, increasing risk of human-to-human transmission.

Keywords: Nigeria; West Africa; human-to-human transmission; immunity; immunoglobulin; monkeypox; neutralizing antibodies; reemerging diseases; smallpox; urbanization; vaccination; viruses; waning immunity; zoonoses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Relationship between population- and individual-level smallpox vaccination and immunity rates and resurgence of monkeypox cases in Nigeria, 1970–2018
Figure 2
Figure 2
Monkeypox in Nigeria and factors affecting spread. A) Case distribution by state, September 2017–September 2020. B) Population density by state in 2016 (gray shading) and nationwide road network in 2018 (black lines)

References

    1. Nigeria Centre for Disease Control and Prevention. Monkeypox monthly situational report, December 2019. [cited 2020 Oct 1]. https://ncdc.gov.ng/themes/common/files/sitreps/5a1a9820f21136842ba43f18...
    1. Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al.; CDC Monkeypox Outbreak Team. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19:872–9. 10.1016/S1473-3099(19)30294-4 - DOI - PMC - PubMed
    1. Sadeuh-Mba SA, Yonga MG, Els M, Batejat C, Eyangoh S, Caro V, et al. Monkeypox virus phylogenetic similarities between a human case detected in Cameroon in 2018 and the 2017-2018 outbreak in Nigeria. Infect Genet Evol. 2019;69:8–11. 10.1016/j.meegid.2019.01.006 - DOI - PMC - PubMed
    1. Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl Trop Dis. 2019;13:e0007791. 10.1371/journal.pntd.0007791 - DOI - PMC - PubMed
    1. Damon IK. Status of human monkeypox: clinical disease, epidemiology and research. Vaccine. 2011;29(Suppl 4):D54–9. 10.1016/j.vaccine.2011.04.014 - DOI - PubMed

Substances

LinkOut - more resources